XSHG688016
Market cap2.00bUSD
Dec 24, Last price
119.10CNY
1D
2.43%
1Q
41.10%
IPO
-19.41%
Name
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Chart & Performance
P/E
29.60
P/S
12.40
EPS
4.02
Div Yield, %
1.14%
Shrs. gr., 5y
7.47%
Rev. gr., 5y
38.44%
Revenues
1.18b
+31.08%
Net income
492m
+37.98%
CFO
571m
+71.15%
Dividend
May 14, 20244.47 CNY/sh
Earnings
Apr 18, 2025
Profile
Shanghai MicroPort Endovascular MedTech Co., Ltd. develops, manufactures, and sells technologies and products in the healthcare business. The company primarily offers solutions for aortic and peripheral diseases. Its products include TAA and AAA stent graft systems, balloon inflation catheters, and PTA balloon dilatation catheters. The company was founded in 2012 and is based in Shanghai, the People's Republic of China. Shanghai MicroPort Endovascular MedTech Co., Ltd. is a subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 1,175,172 31.08% | 896,500 30.95% | 684,631 45.59% | |||||
Cost of revenue | 553,039 | 482,466 | 338,654 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 622,134 | 414,034 | 345,977 | |||||
NOPBT Margin | 52.94% | 46.18% | 50.53% | |||||
Operating Taxes | 85,050 | 61,845 | 48,148 | |||||
Tax Rate | 13.67% | 14.94% | 13.92% | |||||
NOPAT | 537,084 | 352,189 | 297,829 | |||||
Net income | 492,432 37.98% | 356,878 12.99% | 315,856 47.17% | |||||
Dividends | (165,550) | (151,154) | (64,780) | |||||
Dividend yield | 1.10% | 1.11% | 0.36% | |||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 11,378 | 9,095 | 8,839 | |||||
Long-term debt | 48,737 | 64,174 | 73,933 | |||||
Deferred revenue | 37,883 | 27,254 | 24,614 | |||||
Other long-term liabilities | 7,618 | 6,318 | 7,839 | |||||
Net debt | (3,028,680) | (1,029,605) | (1,199,066) | |||||
| Cash flow | ||||||||
Cash from operating activities | 571,223 | 333,761 | 300,253 | |||||
CAPEX | (190,260) | |||||||
Cash from investing activities | (177,094) | |||||||
Cash from financing activities | 1,601,313 | |||||||
FCF | 443,039 | 165,928 | 207,464 | |||||
| Balance | ||||||||
Cash | 2,966,931 | 976,893 | 1,243,238 | |||||
Long term investments | 121,864 | 125,981 | 38,599 | |||||
Excess cash | 3,030,036 | 1,058,049 | 1,247,606 | |||||
Stockholders' equity | 1,199,305 | 974,894 | 754,369 | |||||
Invested Capital | 2,745,518 | 831,930 | 832,874 | |||||
ROIC | 30.03% | 42.31% | 36.69% | |||||
ROCE | 15.77% | 22.92% | 21.80% | |||||
| EV | ||||||||
Common stock shares outstanding | 77,352 | 71,978 | 71,978 | |||||
Price | 194.63 2.96% | 189.04 -24.00% | 248.74 -0.98% | |||||
Market cap | 15,055,059 10.64% | 13,606,748 -24.00% | 17,903,845 -0.98% | |||||
EV | 12,046,138 | 12,601,099 | 16,732,593 | |||||
EBITDA | 657,404 | 447,205 | 369,688 | |||||
EV/EBITDA | 18.32 | 28.18 | 45.26 | |||||
Interest | 1,822 | 2,087 | 1,772 | |||||
Interest/NOPBT | 0.29% | 0.50% | 0.51% | |||||